Mitchell Machtay, MD - Penn State Cancer Institute
Researcher Profile
Mitchell Machtay, MD
Associate Dean for Clinical Cancer Research, Penn State College of Medicine
Professor, Department of Radiation Oncology
Professor, Department of Medicine
Professor, Department of Radiation Oncology
Professor, Department of Medicine
Scientific Program:Next-Generation Therapies
Disease Teams:
Cancer Institute, Brain and Central Nervous System Cancer Team
Cancer Institute, Head and Neck Cancer Team
Cancer Institute, Thoracic Cancer Team
Cancer Institute, Head and Neck Cancer Team
Cancer Institute, Thoracic Cancer Team
Research Interests
- Radiotherapy
- Therapeutics
- Survival
- Non-Small Cell Lung Carcinoma
- Neoplasms
- Head and Neck Neoplasms
- Radiation
- Radiation Oncology
- Radiosurgery
- Neoplasm Metastasis
- Drug Therapy
- Squamous Cell Carcinoma of Head and Neck
Clinical Trials
Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
A Randomized, Phase 2 Study of Stereotactic Body Radiation Therapy (SBRT) in combination with GC4711 in the Treatment of Unresectable or Borderline Resectable, Nonmetastatic Pancreatic Cancer
NRG-LU007 Randomized Phase II/III Trial Of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR trial
S1914 A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT versus SBRT Alone in High Risk, Early Stage NSCLC
NRG-BN012: A Randomized Phase III Trial of Pre-Operative Compared to Post-Operative Stereotactic Radiosurgery in Patients With Resectable Brain Metastases
KEYSTROKE: A Randomized Phase II Study of Pembrolizumab (KEYTRUDA®) Plus Stereotactic Re-irradiation Versus SBRT Alone for Locoregionally Recurrent or Second Primary Head and Neck Carcinoma
S1827 A randomized Phase III trial comparing prophylactic cranial irradiation (PCI) for any patient with small cell lung cancer (either extensive or limited stage) to active surveillance with MRI in place of PCI
Randomized Phase III Trial of MEDI4736 (durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable Stage 3 NSCLC
A Phase II/III Randomized Study of Maintenance Nivolumab versus Observation in Patients with Locally Advanced, Intermediate Risk HPV Positive OPCA
NRG HN009- Randomized Phase II/III Trial of Radiation with High-Dose Cisplatin (100 mg/m2) Every Three Weeks Versus Radiation with Low-Dose Weekly Cisplatin (40 mg/m2) for Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy With or Without SBRT for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer
Recent Publications
2023
Rogers, CL, Pugh, SL, Vogelbaum, MA, Perry, A, Ashby, LS, Modi, JM, Alleman, AM, Barani, IJ, Braunstein, S, Bovi, JA, de Groot, JF, Whitton, AC, Lindhorst, SM, Deb, N, Shrieve, DC, Shu, HK, Bloom, B, Machtay, M, Mishra, MV, Robinson, CG, Won, M & Mehta, MP 2023, 'Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539', Neuro-oncology, vol. 25, no. 1, pp. 137-145. https://doi.org/10.1093/neuonc/noac137
2022
Deshpande, SR, Grubb, WR, Kharouta, M, Zhang, Y, Zheng, Y, Podder, TK, Towe, C, Young, B, Machtay, M & Biswas, T 2022, 'A Comparative Study of Patients With Early-Stage Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy Using CyberKnife and Linear Accelerator–Based Volumetric Modulated Arc Therapy', Practical Radiation Oncology, vol. 12, no. 3, pp. 200-209. https://doi.org/10.1016/j.prro.2021.12.011
Oh, S, Awan, MJ, Monroe, JI, Liang, Y, Wegner, RE, Karlovits, S, Machtay, M, Lo, SS, Sloan, A & Sohn, JW 2022, 'A volume-independent conformity index for stereotactic radiosurgery', Medical Physics, vol. 49, no. 5, pp. 2931-2937. https://doi.org/10.1002/mp.15619
Biswas, T, Dowlati, A, Kunos, CA, Pink, JJ, Oleinick, NL, Malik, S, Fu, P, Cao, S, Bruno, DS, Bajor, DL, Patel, M, Gerson, SL & Machtay, M 2022, 'Adding Base-Excision Repair Inhibitor TRC102 to Standard Pemetrexed-Platinum-Radiation in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer: Results of a Phase I Trial', Clinical Cancer Research, vol. 28, no. 4, pp. 646-652. https://doi.org/10.1158/1078-0432.CCR-21-2025
Gillison, ML, Ferris, RL, Harris, J, Colevas, AD, Mell, LK, Kong, C, Jordan, RC, Moore, KL, Truong, MT, Kirsch, C, Chakravarti, A, Blakaj, DM, Clump, DA, Ohr, JP, Deeken, JF, Gensheimer, MF, Saba, NF, Dorth, JA, Rosenthal, DI, Leidner, RS, Kimple, RJ, Machtay, M, Curran, WJ, Torres-Saavedra, P & Le, QT 2023, 'Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504', International Journal of Radiation Oncology Biology Physics, vol. 115, no. 4, pp. 847-860. https://doi.org/10.1016/j.ijrobp.2022.10.008
Damico, NJ, Deshane, A, Kharouta, M, Wu, A, Wang, GM, Machtay, MX, Kumar, A, Choi, S & Bhatt, AD 2022, 'Telemedicine Use and Satisfaction Among Radiation Oncologists During the COVID-19 Pandemic: Evaluation of Current Trends and Future Opportunities', Advances in Radiation Oncology, vol. 7, no. 2, 100835. https://doi.org/10.1016/j.adro.2021.100835
2021
Kang, KH, Efird, JT, Podder, TK, Zhang, Y, Dowlati, A, Machtay, M, Jindal, C & Biswas, T 2021, 'A pilot study examining the prognostic utility of tumor shrinkage on cone-beam computed tomography (Cbct) for stage iii locally advanced non-small cell lung cancer patients treated with definitive chemoradiation', International journal of environmental research and public health, vol. 18, no. 6, 3241, pp. 1-8. https://doi.org/10.3390/ijerph18063241
Grubb, WR, Ponsky, L, Lo, SS, Kharouta, M, Traughber, B, Sandstrom, K, MacLennan, GT, Shankar, E, Gupta, S, Machtay, M & Ellis, RJ 2021, 'Final results of a dose escalation protocol of stereotactic body radiotherapy for poor surgical candidates with localized renal cell carcinoma', Radiotherapy and Oncology, vol. 155, pp. 138-143. https://doi.org/10.1016/j.radonc.2020.10.031
Fredman, E, Traughber, B, Kharouta, M, Podder, T, Lo, S, Ponsky, L, MacLennan, G, Paspulati, R, Ellis, B, Machtay, M & Ellis, R 2021, 'Focal Prostate Stereotactic Body Radiation Therapy With Correlative Pathological and Radiographic-Based Treatment Planning', Frontiers in Oncology, vol. 11, 744130. https://doi.org/10.3389/fonc.2021.744130
Jin, JY, Hu, C, Xiao, Y, Zhang, H, Paulus, R, Ellsworth, SG, Schild, SE, Bogart, JA, Dobelbower, MC, Kavadi, VS, Narayan, S, Iyengar, P, Robinson, C, Greenberger, JS, Koprowski, C, Machtay, M, Curran, W, Choy, H, Bradley, JD & Kong, FM 2021, 'Higher radiation dose to the immune cells correlates with worse tumor control and overall survival in patients with stage iii nsclc: A secondary analysis of rtog0617', Cancers, vol. 13, no. 24, 6193. https://doi.org/10.3390/cancers13246193
Yu, Y, Fu, P, Jin, JY, Gao, S, Wang, W, Machtay, M, Wang, L, Kong, FM & Yu, J 2021, 'Impact of effective dose to immune cells (EDIC) on lymphocyte nadir and survival in limited-stage SCLC', Radiotherapy and Oncology, vol. 162, pp. 26-33. https://doi.org/10.1016/j.radonc.2021.06.020
Patil, N, Somasundaram, E, Waite, KA, Lathia, JD, Machtay, M, Gilbert, MR, Connor, JR, Rubin, JB, Berens, ME, Buerki, RA, Choi, S, Sloan, AE, Penas-Prado, M, Ashby, LS, Blumenthal, DT, Werner-Wasik, M, Hunter, GK, Flickinger, JC, Wendland, MM, Panet-Raymond, V, Robins, HI, Pugh, SL, Mehta, MP & Barnholtz-Sloan, JS 2021, 'Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825', Journal of neuro-oncology, vol. 155, no. 3, pp. 363-372. https://doi.org/10.1007/s11060-021-03886-5
Yuan, J, Fredman, E, Jin, JY, Choi, S, Mansur, D, Sloan, A, Machtay, M & Zheng, Y 2021, 'Monte Carlo Dose Calculation Using MRI Based Synthetic CT Generated by Fully Convolutional Neural Network for Gamma Knife Radiosurgery', Technology in Cancer Research and Treatment, vol. 20. https://doi.org/10.1177/15330338211046433
Biswas, T, Gawdi, R, Jindal, C, Iyer, S, Kang, KH, Bajor, D, Machtay, M, Choi, YM & Efird, JT 2021, 'Pretreatment neutrophil-to-lymphocyte ratio as an important prognostic marker in stage III locally advanced non-small cell lung cancer: Confirmatory results from the PROCLAIM phase III clinical trial', Journal of Thoracic Disease, vol. 13, no. 10, pp. 5617-5626. https://doi.org/10.21037/jtd-21-1018
Sheikh, S, Kharouta, MZ, Pidikiti, R, Damico, NJ, Choi, S, Dorth, JA, Mansur, DB, Machtay, MX, Yao, M & Bhatt, AD 2022, 'Proton Beam Therapy for Locally Advanced Head and Neck Tumors: An Analysis of Dosimetric and Clinical Outcomes', American Journal of Clinical Oncology: Cancer Clinical Trials, vol. 45, no. 2, pp. 81-87. https://doi.org/10.1097/COC.0000000000000883
Damico, NJ, Wu, AK, Kharouta, MZ, Eitan, T, Pidikiti, R, Jesseph, FB, Smith, M, Langmack, C, Mattson, DL, Dobbins, D, Mansur, DB, Machtay, MX, Dorth, JA, Choi, S, Yao, M & Bhatt, AD 2021, 'Proton beam therapy in the treatment of periorbital malignancies', International Journal of Particle Therapy, vol. 7, no. 4, pp. 42-51. https://doi.org/10.14338/IJPT-20-00025.1
Tchelebi, LT, Batchelder, E, Wang, M, Lehrer, EJ, Drabick, JJ, Sharma, N, MacHtay, M, Trifiletti, DM & Zaorsky, NG 2021, 'Radiotherapy and Receptor Tyrosine Kinase Inhibition for Solid Cancers (ROCKIT): A Meta-Analysis of 13 Studies', JNCI Cancer Spectrum, vol. 5, no. 4, pkab050. https://doi.org/10.1093/jncics/pkab050
Awan, MJ, Gittleman, H, Barnholtz-Sloan, J, Machtay, M, Nguyen-Tan, PF, Rosenthal, DI, Schultz, C, Huth, BJ, Thorstad, WL, Frank, SJ, Kim, H, Foote, RL, Lango, MN, Shenouda, G, Suntharalingam, M, Harris, J, Zhang, Q, Le, QT & Yao, M 2021, 'Risk groups of laryngeal cancer treated with chemoradiation according to nomogram scores – A pooled analysis of RTOG 0129 and 0522', Oral Oncology, vol. 116, 105241. https://doi.org/10.1016/j.oraloncology.2021.105241
Sheikh, S, Dey, A, Datta, S, Podder, TK, Jindal, C, Dowlati, A, Efird, JT, Machtay, M & Biswas, T 2021, 'Role of radiation in extensive stage small cell lung cancer: A National Cancer Database registry analysis', Future Oncology, vol. 17, no. 21, pp. 2713-2724. https://doi.org/10.2217/fon-2020-1095
2020
Jin, JY, Mereniuk, T, Yalamanchali, A, Wang, W, Machtay, M, (Spring)Kong, FM & Ellsworth, S 2020, 'A framework for modeling radiation induced lymphopenia in radiotherapy', Radiotherapy and Oncology, vol. 144, pp. 105-113. https://doi.org/10.1016/j.radonc.2019.11.014
Wang, W, Huang, L, Jin, JY, Pi, W, Ellsworth, SG, Jolly, S, Mellor, AL, Machtay, M & Kong, FM 2020, 'A validation study on IDO immune biomarkers for survival prediction in non–small cell lung cancer: Radiation dose fractionation effect in early-stage disease', Clinical Cancer Research, vol. 26, no. 1, pp. 282-289. https://doi.org/10.1158/1078-0432.CCR-19-1202
Rogers, LR, Ostrom, QT, Schroer, J, Vengoechea, J, Li, L, Gerson, S, Nock, CJ, Machtay, M, Selman, W, Lo, S, Sloan, AE & Barnholtz-Sloan, JS 2020, 'Association of metabolic syndrome with glioblastoma: A retrospective cohort study and review', Neuro-Oncology Practice, vol. 7, no. 5, pp. 541-548. https://doi.org/10.1093/nop/npaa011
Wang, W, Matuszak, MM, Hu, C, Huang, KC, Chen, E, Arenberg, D, Curtis, JL, Jolly, S, Jin, JY, Machtay, M, Ten Haken, RK & Kong, FM 2020, 'Central Airway Toxicity After High Dose Radiation: A Combined Analysis of Prospective Clinical Trials for Non-Small Cell Lung Cancer', International Journal of Radiation Oncology Biology Physics, vol. 108, no. 3, pp. 587-596. https://doi.org/10.1016/j.ijrobp.2020.05.026
Sohn, JW, Kim, H, Park, SB, Lee, S, Monroe, JI, Malone, TB, Kinsella, T, Yao, M, Kunos, C, Lo, SS, Shenk, R & Machtay, M 2020, 'Clinical Study of Using Biometrics to Identify Patient and Procedure', Frontiers in Oncology, vol. 10, 586232. https://doi.org/10.3389/fonc.2020.586232
Worrell, SG, Towe, CW, A. Dorth, J, Machtay, M, Perry, Y & Linden, PA 2020, 'Higher Doses of Neoadjuvant Radiation for Esophageal Cancer Do Not Affect the Pathologic Complete Response Rate or Survival: A Propensity-Matched Analysis', Annals of Surgical Oncology, vol. 27, no. 2, pp. 500-508. https://doi.org/10.1245/s10434-019-07849-z
Eitz, KA, Lo, SS, Soliman, H, Sahgal, A, Theriault, A, Pinkham, MB, Foote, MC, Song, AJ, Shi, W, Redmond, KJ, Gui, C, Kumar, AMS, MacHtay, M, Meyer, B & Combs, SE 2020, 'Multi-institutional Analysis of Prognostic Factors and Outcomes after Hypofractionated Stereotactic Radiotherapy to the Resection Cavity in Patients with Brain Metastases', JAMA Oncology, vol. 6, no. 12, pp. 1901-1909. https://doi.org/10.1001/jamaoncol.2020.4630
Gensheimer, MF, Yom, SS, Soto, N, Dignam, JJ, Le, QT, Machtay, M & Curran, WJ 2020, 'Multicenter Clinical Cancer Research After COVID-19: A Perspective From NRG Oncology', International Journal of Radiation Oncology Biology Physics, vol. 108, no. 2, pp. 483-485. https://doi.org/10.1016/j.ijrobp.2020.06.056
Yu, Y, Wang, L, Cao, S, Gao, S, Wang, W, Mulvihill, L, Machtay, M, Fu, P, Yu, J & Kong, FM 2020, 'Pre-radiotherapy lymphocyte count and platelet-to-lymphocyte ratio may improve survival prediction beyond clinical factors in limited stage small cell lung cancer: Model development and validation', Translational Lung Cancer Research, vol. 9, no. 6, pp. 2315-2327. https://doi.org/10.21037/tlcr-20-666
Jin, JY, Gu, A, Wang, W, Oleinick, NL, Machtay, M & (Spring) Kong, FM 2020, 'Ultra-high dose rate effect on circulating immune cells: A potential mechanism for FLASH effect?', Radiotherapy and Oncology, vol. 149, pp. 55-62. https://doi.org/10.1016/j.radonc.2020.04.054
Biswas, T, Kang, KH, Gawdi, R, Bajor, D, Machtay, M, Jindal, C & Efird, JT 2020, 'Using the systemic immune-inflammation index (SII) as a mid-treatment marker for survival among patients with stage-III locally advanced non-small cell lung cancer (NSCLC)', International journal of environmental research and public health, vol. 17, no. 21, 7995, pp. 1-13. https://doi.org/10.3390/ijerph17217995
2019
Chen, X, Zheng, Y, Tatsuoka, C, Muzic, RF, Okoye, CC, O'Donnell, JK, Zidar, D, Avril, N, Oliveira, GH, Liu, H, Bucher, J, Machtay, M, Yao, M & Dorth, JA 2019, 'Chemoradiotherapy-related carotid artery inflammation in head and neck cancer patients quantified by [18F]FDG PET/CT', Oral Oncology, vol. 93, pp. 101-106. https://doi.org/10.1016/j.oraloncology.2019.04.008
Fredman, ET, Traughber, BJ, Gross, A, Podder, T, Colussi, V, Vinkler, R, Machtay, M & Ellis, RJ 2019, 'Comparison of multiparametric MRI-based and transrectal ultrasound-based preplans with intraoperative ultrasound-based planning for low dose rate interstitial prostate seed implantation', Journal of applied clinical medical physics, vol. 20, no. 6, pp. 31-38. https://doi.org/10.1002/acm2.12592
Grubb, WR, Machtay, M, Dowlati, A & Biswas, T 2019, 'Diffuse Atypical Cystic Brain Metastases in ALK+ NSCLC Treated With Whole Brain Radiation and Second-Generation ALK-Targeted Therapy', Practical Radiation Oncology, vol. 9, no. 2, pp. e129-e133. https://doi.org/10.1016/j.prro.2018.11.002
Hayman, JA, Dekker, A, Feng, M, Keole, SR, McNutt, TR, Machtay, M, Martin, NE, Mayo, CS, Pawlicki, T, Smith, BD, Kudner, R, Dawes, S & Yu, JB 2019, 'Minimum Data Elements for Radiation Oncology: An American Society for Radiation Oncology Consensus Paper', Practical Radiation Oncology, vol. 9, no. 6, pp. 395-401. https://doi.org/10.1016/j.prro.2019.07.017
Li, Y, Awan, MJ, Chang, T, Lavertu, P, Zender, C, Rezaee, R, Fowler, N, Wasman, J, Avril, NE, Chen, N, Machtay, M & Yao, M 2019, 'Post-radiotherapy PET/CT for predicting treatment outcomes in head and neck cancer after postoperative radiotherapy', European Journal of Nuclear Medicine and Molecular Imaging, vol. 46, no. 4, pp. 794-800. https://doi.org/10.1007/s00259-019-4272-8
Bovi, JA, Pugh, SL, Sabsevitz, D, Robinson, CG, Paulson, E, Mehta, MP, Gondi, V, Kundapur, V, Shahin, MS, Chao, ST, Machtay, M, DeNittis, AS, Laack, NN, Greenspoon, JN, Moore, KN, Huang, J, Dominello, MM & Kachnic, LA 2019, 'Pretreatment Volume of MRI-Determined White Matter Injury Predicts Neurocognitive Decline After Hippocampal Avoidant Whole-Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology Radiation Therapy Oncology Group 0933', Advances in Radiation Oncology, vol. 4, no. 4, pp. 579-586. https://doi.org/10.1016/j.adro.2019.07.006